Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Details 1)

v3.23.3
NET LOSS PER SHARE (Details 1) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Equity Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive shares 7,335,035 7,931,652 7,335,035 7,931,652
Restricted Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive shares 4,059,869 6,360 4,059,869 6,360
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive shares [1] 12,045,000 21,045,775 17,855,467 21,045,775
Convertible Notes [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive shares [1] 9,729,163 9,729,163 9,729,163 9,729,163
[1] The public and private warrants and Convertible Notes referred to in Notes 11 and 14 were excluded on an as converted basis because their effect would have been anti-dilutive for the three and nine months ended September 30, 2023. The Fortress warrants referred to in Notes 11 and 14 were also excluded on an as converted basis because their effect would have been anti-dilutive for the nine months ended September 30, 2023.